The risk of anaphylactic reactions to rocuronium in the United States is comparable to that of vecuronium: An analysis of food and drug administration reporting of adverse events

Anesthesia and Analgesia

Volumn 101, Issue 3, 2005, Pages 819-822

  Bhananker, Sanjay M ^a,d   O'Donnell, James T ^b   Salemi, John R ^c   Bishop, Michael J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c Pharmaconsultant Inc   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CISATRACURIUM; ROCURONIUM; VECURONIUM;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ARTICLE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HUMAN; INCIDENCE; PRIORITY JOURNAL; RISK; UNITED STATES;

EID: 23944451166     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000175213.87556.D8     Document Type: Article

References (25)

1. Laxenaire MC. Epidemiology of anesthetic anaphylactoid reactions: fourth multicenter survey (July 1994-December 1996) [in French] Ann Fr Anesth Reanim 1999;18:796-809.
2. Fisher MM, Baldo BA. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993;12:97-104.
3. Vervloet D, Durham S. Adverse reactions to drugs. BMJ 1998; 316:1511-4.
4. Mertes PM, Laxenaire MC. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002;19:240-62.
5. Beard K, Jick H. Cardiac arrest and anaphylaxis with anesthetic agents. JAMA 1985;254:2742.
6. Mertes PM, Laxenaire MC. Adverse reactions to neuromuscular blocking agents. Curr Allergy Asthma Rep 2004;4:7-16.
7. Mertes PM, Laxenaire MC. Allergy and anaphylaxis in anaesthesia. Minerva Anestesiol 2004;70:285-91.
8. Mertes PM, Laxenaire MC, Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003;99:536-45.
9. Amedeo J, Occelli G, Pradier C, Grimaud D. Impact of the development of anesthesia protocols on the incidence of perianesthetic anaphylactoid reactions [in French]. Allerg Immunol (Paris) 2002;34:277-80.
10. Garvey LH, Roed-Petersen J, Menne T, Husum B. Danish Anaesthesia Allergy Centre: preliminary results. Acta Anaesthesiol Scand 2001;45:1204-9.
11. Guttormsen AB. Allergic reactions during anaesthesia: increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001;45:1189-90.
12. Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia: results of a two-year survey in France. Br J Anaesth 2001;87: 549-58.
13. Rose M, Fisher M. Rocuronium: high risk for anaphylaxis? Br J Anaesth 2001;86:678-82.
14. Watkins J. Incidence of UK reactions involving rocuronium may simply reflect market use. Br J Anaesth 2001;87:522.
15. Ebo DG, Hagendorens MM, Bridts CH, et al. Allergic reactions occurring during anaesthesia: diagnostic approach. Acta Clin Belg 2004;59:34-43.
16. Dhonneur G, Combes X, Chassard D, Merle JC. Skin sensitivity to rocuronium and vecuronium: a randomized controlled prick-testing study in healthy volunteers. Anesth Analg 2004;98: 986-9.
17. Porri F, Lemiere C, Birnbaum J, et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999;29:72-5.
18. Koppert W, Blunk JA, Petersen LJ, et al. Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology 2001;95:659-67.
19. Levy JH. Anaphylactic reactions to neuromuscular blocking drugs: are we making the correct diagnosis? Anesth Analg 2004;98:881-2.
20. Esmeron (rokuroniumbromid) Og risiko for anafylaksi - hva er status? Available at http://www.legemiddelverket.no/bivirk/prepfok/esmeron2003.htm, Accessed December 21, 2004.
21. Rothman KJ, Lanes S, Sacks ST. The reporting odds ratio and its advantages over the proportional reporting ratio. Pharmacoepidemiol Drug Saf 2004;13:519-23.
22. Hartnell NR, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. Pharmacotherapy 2004;24:743-9.
23. Domino KB, Bowdle TA, Posner KL, et al. Injuries and liability related to central vascular catheters: a closed claims analysis. Anesthesiology 2004;100:1411-8.
24. Domino KB, Posner KL, Caplan RA, Cheney FW. Awareness during anesthesia: a closed claims analysis. Anesthesiology 1999;90:1053-61.
25. Harris G. At FDA, Strong Drug Ties and Less Monitoring. New York Times, December 6, 2004.